Avita Medical (RCEL) vs Tactile Systems Technology (TCMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Avita Medical (RCEL) has outperformed Tactile Systems Technology (TCMD) over the past year, gaining 141.9% versus a gain of 48.5%. Over five years, RCEL leads with a -23.3% price change compared with -38.0% for TCMD. Tactile Systems Technology is the larger company by market cap ($501.1 million vs $412.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RCEL | TCMD |
|---|---|---|
| Share price | $13.33 | $22.12 |
| Market cap | $412.25M | $501.07M |
| 1-day change | +2.15% | +0.45% |
| YTD return | +286.38% | -23.72% |
| 1-year return | +141.92% | +48.46% |
| 5-year return | -23.26% | -37.97% |
| P/E ratio (TTM) | — | 20.48 |
| Forward P/E | — | 15.20 |
| EPS (TTM) | $-1.43 | $1.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.50 | $37.77 |
| 52-week low | $3.22 | $14.00 |
| Distance from 52-week high | -1.26% | -41.44% |
| Analyst consensus | none | none |
| Avg. price target upside | -9.75% | +76.31% |
| Average volume | 442.74K | 294.43K |
| Shares outstanding | 30.93M | 22.65M |
| Employees | 226 | 1,086 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RCEL has outperformed TCMD by 93.5 percentage points over the past year.
About Avita Medical
RCEL stock →AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.
Health Care · Medical/Dental Instruments · 226 employees
About Tactile Systems Technology
TCMD stock →Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.
Health Care · Medical/Dental Instruments · 1,086 employees
RCEL vs TCMD FAQ
Which is bigger, Avita Medical or Tactile Systems Technology?
Tactile Systems Technology (TCMD) is larger, with a market capitalization of $501.07M compared with $412.25M for Avita Medical (RCEL).
Which stock has performed better over the past year, RCEL or TCMD?
RCEL returned +141.92% over the past 12 months, compared with +48.46% for TCMD (price return, excluding dividends). Past performance does not predict future results.
Are Avita Medical and Tactile Systems Technology in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.